Servier Laboratories is a privately owne French pharmaceutical company that specialises in medication for cardiological and rheumatological conditions, as well as for diabetes and clinical depression. The consolidated turnover for the 2005/2006 financial year was €3.5 billion. Servier is the leading French independent pharmaceutical company, and the second French pharmaceutical company worldwide. It has branches in 140 countries, with 82% of its sales being achieved internationally. The annual sales of its ACE inhibitor,Coversyl(perindopril)for past 2 consecutive years(2006 and 2007)exceeded US$1.0 bio thus making it Servier's first block-buster.